These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 7530029)

  • 41. Recombinant aprotinin in coronary artery bypass graft operations.
    Green D; Sanders J; Eiken M; Wong CA; Frederiksen J; Joob A; Palmer A; Trowbridge A; Woodruff B; Moerch M
    J Thorac Cardiovasc Surg; 1995 Oct; 110(4 Pt 1):963-70. PubMed ID: 7475162
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Aprotinin counteracts heparin-induced inhibition of platelet contractile force.
    Carr ME; Carr SL; Roa V; McCardell KA; Greilich PE
    Thromb Res; 2002 Nov; 108(2-3):161-8. PubMed ID: 12590953
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Protamine reduces whole blood platelet aggregation after cardiopulmonary bypass.
    Olsson A; Alfredsson J; Håkansson E; Svedjeholm R; Berglund J; Berg S
    Scand Cardiovasc J; 2016; 50(1):58-63. PubMed ID: 26402229
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Recombinant hirudin as an anticoagulant during cardiac operations: experiments in a pig model.
    Riess FC; Pötzsch B; Behr I; Jäger K; Rössing R; Bleese N; Schaper W; Müller-Berghaus G
    Eur J Cardiothorac Surg; 1997 Apr; 11(4):739-45. PubMed ID: 9151047
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effect of high or low protamine dosing on postoperative bleeding following heparin anticoagulation in cardiac surgery. A randomised clinical trial.
    Meesters MI; Veerhoek D; de Lange F; de Vries JW; de Jong JR; Romijn JW; Kelchtermans H; Huskens D; van der Steeg R; Thomas PW; Burtman DT; van Barneveld LJ; Vonk AB; Boer C
    Thromb Haemost; 2016 Aug; 116(2):251-61. PubMed ID: 27277211
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The influence of aprotinin and tranexamic acid on platelet function and postoperative blood loss in cardiac surgery.
    Mengistu AM; Röhm KD; Boldt J; Mayer J; Suttner SW; Piper SN
    Anesth Analg; 2008 Aug; 107(2):391-7. PubMed ID: 18633013
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Aprotinin decreases postoperative bleeding and number of transfusions in patients on clopidogrel undergoing coronary artery bypass graft surgery: a double-blind, placebo-controlled, randomized clinical trial.
    van der Linden J; Lindvall G; Sartipy U
    Circulation; 2005 Aug; 112(9 Suppl):I276-80. PubMed ID: 16159831
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Inhibition of platelet adhesion during cardiopulmonary bypass reduces postoperative bleeding.
    Uthoff K; Zehr KJ; Geerling R; Herskowitz A; Cameron DE; Reitz BA
    Circulation; 1994 Nov; 90(5 Pt 2):II269-74. PubMed ID: 7955264
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Platelet protection by low-dose aprotinin in cardiopulmonary bypass: electron microscopic study.
    Lavee J; Raviv Z; Smolinsky A; Savion N; Varon D; Goor DA; Mohr R
    Ann Thorac Surg; 1993 Jan; 55(1):114-9. PubMed ID: 7678061
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Does heparin pretreatment affect the haemostatic system during and after cardiopulmonary bypass?
    Brinks HJ; Weerwind PW; Bogdan S; Verbruggen H; Brouwer MH
    Perfusion; 2001 Jan; 16(1):3-12. PubMed ID: 11192305
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Heparin management during cardiac surgery with respect to various blood-conservation techniques.
    Boldt J; Zickmann B; Herold C; Scholz S; Dapper F; Hempelmann G
    Surgery; 1992 Mar; 111(3):260-5. PubMed ID: 1542853
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Randomized study of aprotinin and DDAVP to reduce postoperative bleeding after cardiopulmonary bypass surgery.
    Rocha E; Hidalgo F; Llorens R; Melero JM; Arroyo JL; Páramo JA
    Circulation; 1994 Aug; 90(2):921-7. PubMed ID: 7519132
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Biocompatibility of heparin-coated extracorporeal bypass circuits: a randomized, masked clinical trial.
    Muehrcke DD; McCarthy PM; Kottke-Marchant K; Harasaki H; Pierre-Yared J; Borsh JA; Ogella DA; Cosgrove DM
    J Thorac Cardiovasc Surg; 1996 Aug; 112(2):472-83. PubMed ID: 8751516
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A single dose of aprotinin prevents platelet hyporeactivity after coronary artery bypass graft surgery.
    Szczeklik W; Morawski W; Sanak M; Jakieła B; Bolkowski M; Cisowski M; Szczeklik M; Bochenek A; Musiał J
    Pol Arch Med Wewn; 2010 Sep; 120(9):321-7. PubMed ID: 20864904
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Inhaled prostacyclin and platelet function after cardiac surgery and cardiopulmonary bypass.
    Haraldsson A; Kieler-Jensen N; Wadenvik H; Ricksten SE
    Intensive Care Med; 2000 Feb; 26(2):188-94. PubMed ID: 10784307
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Perioperative course and recovery after heparin-coated cardiopulmonary bypass: low-dose versus high-dose heparin management.
    Weiss BM; von Segesser LK; Turina MI; Seifert B; Pasch T
    J Cardiothorac Vasc Anesth; 1996 Jun; 10(4):464-70. PubMed ID: 8776638
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Does continuous heparinization influence platelet function in the intensive care patient?
    Boldt J; Müller M; Rothe A; Lenzen P; Hempelmann G
    Intensive Care Med; 1997 May; 23(5):567-73. PubMed ID: 9201530
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Early platelet recovery following cardiac surgery with cardiopulmonary bypass.
    Van Poucke S; Stevens K; Wetzels R; Kicken C; Verhezen P; Theunissen M; Kuiper G; van Oerle R; Henskens Y; Lancé M
    Platelets; 2016 Dec; 27(8):751-757. PubMed ID: 27164510
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Low-dose heparin versus full-dose heparin with high-dose aprotinin during cardiopulmonary bypass. A preliminary report.
    von Segesser LK; Garcia E; Turina MI
    Tex Heart Inst J; 1993; 20(1):28-32. PubMed ID: 7685221
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effects of aprotinin during cardiopulmonary bypass in patients treated with acetylsalicylic acid.
    Ivert T; Intonti M; Stain-Malmgren R; Dumitrescu A; Blombäck M
    Scand Cardiovasc J; 1998; 32(5):289-95. PubMed ID: 9835004
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.